[EN] OREXIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE
申请人:BENEVOLENTAI BIO LTD
公开号:WO2018146466A1
公开(公告)日:2018-08-16
The present invention relates to orexin receptor antagonists, pharmaceutical compositions comprising the antagonists, methods of making the antagonists, their use for the modulation of the orexin receptor, and to use of the antagonists as medicaments, in particular for treating diseases, disorders, or conditions mediated by orexin receptor activity. More specifically, there is provided a compound of Formula (I) including salts thereof, polymorphs, and isomers thereof (including optical, geometric and tautomeric isomers) as defined herein and isotopically-labelled compounds of Formula (I).
本发明涉及促进素受体拮抗剂、包含该拮抗剂的药物组合物、制备该拮抗剂的方法、其用于调节促进素受体的用途,以及将该拮抗剂用作药物,特别是用于治疗由促进素受体活性介导的疾病、障碍或病情。更具体地,本发明提供了一种包括其盐、多晶体和其异构体(包括光学、几何和互变异构体)以及公式(I)的同位素标记化合物的化合物。